维普期刊资源整合服务平台（V6.5）

181篇 您的检索式：作者名="Burnett JC Jr"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Ca- rotidartery atheroma: comparison of preoperative B-mode ul-tra- sound appearance with carotid endarterectomy speci-men pa- thology显示文摘	ray-Weale AC Graham JC Burnett JR	1988	Cardiovasc Surg1988，29，6：	1
2	Alternate cir-culating pro-B-type natriuretic peptide and B-type natriureticpeptide forms in the general population显示文摘	Lam CS Burnett JC Jr Costello-Boerrigter L	2007	J Am Coll Cardiol2007，49，11：	1
3	Novel therapeutic directions for the natriuretie peptides in cardiovascular diseases : what' s on the horizon 显示文摘	Burnett JC Jr	2006	J cardiol2006，48，5：	1
4	Matrix metalloproteinases : pathways of induction by bio- active molecules显示文摘	Tsuruda T Costello - Boerrigter LC Burnett JC Jr	2004	Heart Fail Rev2004，9，1：	1
5	Short term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘	Gheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
6	Effects of oral tolvaptan in patients hospitalized for worsening heart {ailure: the EVEREST Outcome Trial显示文摘	Gheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
7	Natriuretic peptide levels in atrial fibrillation:a prospective hormonal and doppler-echocardiographic study显示文摘	Rossi A Enriquez SM Burnett JC Jr	2000	J Am Coll Cardiol2000，35，5：	1
8	Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? 显示文摘	CORTI R BURNETT JC Jr ROULEAU JL	2001	Circulation2001，104，15：	1
9	Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial显示文摘	Konstam MA Gheorghiade M Burnett JC Jr	2007	JAMA2007，297，2：	1
10	Increase and uncoupling of adrenomedullin from thenatriuretic peptide system in aneurismal subarachnoid hemorrage显示文摘	Heublein DM Burnett JC Jr	2001	J Neurosurg2001，94，：	1
11	Use of plasma brainnat- riuretic peptide concentration to aid in the diagnosis of heart failure 显示文摘	Shapiro BP Hen HH Burnett JC JR	2003	Mayo Clin Proe2003，78，4：	1
12	Natriurctic peptide system and endothelin in aneurismal subaraehnoid hemorrhage显示文摘	Wijdieks EFM Sehievink WI Burnett JC Jr	1997	J Neurosurg1997，87，3：	1
13	Burden of systolic and diastolic ventricular dysfunction in the community:appreciating the scope of the heart failure epidemic 显示文摘	Redfield MM Jacobsen SJ Burnett JC Jr	2003	JAMA2003，289，2：	1
14	Matrix metallopro- teinases: pathways of induction by bioaetive molecules 显示文摘	Tsuruda T Costelloboerrigter LC Burnett Jr JC	2004	Heart FailRev2004，9，1：	1
15	Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic 显示文摘	Redfield MM Jacobsen SJ Burnett JC Jr	2003	JAMA2003，289，2：	1
16	Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘	Cheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
17	Alter-nate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population显示文摘	Lam CS Burnett JC Jr Costello-Boerrigter L	2007	J Am Coll Cardiol2007，49，11：	1
18	Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and dias- tolic dysfunction and ventricular hypertrophy 显示文摘	Yamamoto K Burnett JC Jr Jougasaki M	1996	Hypertension1996，28，6：	1
19	Vasopeptidase inhibition:a new concept in blood pressure management 显示文摘	Burnett JC Jr	1999	Hypertens Suppl1999，17，1：	1
20	Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure显示文摘	Shapiro BP Chen H H Burnett JC Jr	2003	Mayo Clin Proc2003，78，4：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示